(Q37220015)

19 August 2017

Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study (English)

1 reference

19 August 2017

0 references

4

Tore Wentzel-Larsen

1 reference

19 August 2017

3

Torleif Ruud

1 reference

19 August 2017

Rune A Kroken

1

1 reference

19 August 2017

Erik Johnsen

series ordinal

2

1 reference

19 August 2017

Hugo A Jørgensen

series ordinal

5

1 reference

19 August 2017

16 May 2009

1 reference

19 August 2017

1 reference

19 August 2017

9

1 reference

19 August 2017

24

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-244x-9-24

19 August 2017

0 references

cites work

Atypical antipsychotic drugs and the risk of sudden cardiac death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Effectiveness of second generation antipsychotics: a systematic review of randomized trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Clinical features and therapeutic management of patients admitted to Italian acute hospital psychiatric units: the PERSEO (psychiatric emergency study and epidemiology) survey

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Practice guideline for the treatment of patients with schizophrenia, second edition.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Chlorpromazine Equivalents Versus Defined Daily Doses: How to Compare Antipsychotic Drug Doses?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Chlorpromazine equivalent doses for the newer atypical antipsychotics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Health of the Nation Outcome Scales (HoNOS). Research and development

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Schizophrenia practice guidelines: international survey and comparison.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Trends in the pharmacological treatment of patients with schizophrenia over a 12 year observation period

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Guideline adherence in medication management of psychotic disorders: an observational multisite hospital study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Practice regarding antipsychotic therapy: a cross-sectional survey in two Norwegian hospitals

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Prescribing for inpatients with schizophrenia: an international multi-center comparative study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693495

Discovering the neural basis of human social anxiety: a diagnostic and therapeutic imperative

3 September 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-9-24

Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-9-24

Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-9-24

Guidelines for depot antipsychotic treatment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-9-24

Medical decision making in antipsychotic drug choice for schizophrenia

21 January 2018

1 reference

12 December 2020

Psychiatric treatment guidelines: doctors' non-compliance or insufficient evidence?

1 reference

12 December 2020

Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence

1 reference

12 December 2020

Long-term combination antipsychotic treatment in VA patients with schizophrenia

1 reference

12 December 2020

Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study

1 reference

12 December 2020

Dose equivalence of the antipsychotic drugs

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-244X-9-24

1 reference

Dimensions Publication ID

19 August 2017

0 references

1 reference

19 August 2017

PubMed publication ID

19445700

1 reference